Publications

Clemens, J.; Holmgren, J.; Kaufmann, S. H. E.; Mantovani, A.: Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress. Nature Immunology 11 (12), pp. 1069 - 1072 (2010)

Thaiss, C. A.; Kaufmann, S. H. E.: Toward Novel Vaccines Against Tuberculosis: Current Hopes and Obstacles. Yale Journal of Biology and Medicine 83 (4), pp. 209 - 215 (2010)

Neves, P.; Lampropoulou, V.; Calderon-Gomez, E.; Roch, T.; Stervbo, U.; Shen, P.; Kühl, A. A.; Loddenkemper, C.; Haury, M.; Nedospasov, S. A. et al.; Kaufmann, S. H. E.; Steinhoff, U.; Calado, D. P.; Fillatreau, S.: Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33 (5), pp. 777 - 790 (2010)

Kaufmann, S. H. E.: News and EFIS. European Journal of Immunology 40 (11), pp. 2967 - 2968 (2010)

Kaufmann, S. H. E.: Future Vaccination Strategies against Tuberculosis: Thinking outside the Box. Immunity 33 (4), pp. 567 - 577 (2010)

Reece, S. T.; Loddenkemper, C.; Askew, D. J.; Zedler, U.; Schommer-Leitner, S.; Stein, M.; Mir, F. A.; Dorhoi, A.; Mollenkopf, H. J.; Silverman, G. A. et al.; Kaufmann, S. H. E.: Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice. Journal of Clinical Investigation 120 (9), pp. 3365 - 3376 (2010)

Darmoise, A.; Teneberg, S.; Bouzonville, L.; Brady, R. O.; Beck, M.; Kaufmann, S. H. E.; Winau, F.: Lysosomal alpha-Galactosidase Controls the Generation of Self Lipid Antigens for Natural Killer T Cells. Immunity 33 (2), pp. 216 - 228 (2010)

Kaufmann, S. H. E.: Learning from natural infection for rational tuberculosis vaccine design From basic science to translational research. Human Vaccines 6 (8), pp. 614 - 618 (2010)

Schmidt, N.; Gonzalez, E.; Visekruna, A.; Kühl, A. A.; Loddenkemper, C.; Mollenkopf, H. J.; Kaufmann, S. H. E.; Steinhoff, U.; Joeris, T.: Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 59 (7), pp. 896 - 906 (2010)

Marais, B. J.; Raviglione, M. C.; Donald, P. R.; Harries, A. D.; Kritski, A. L.; Graham, S. M.; El-Sadr, W. M.; Harrington, M.; Churchyard, G.; Mwaba, P. et al.; Sanne, I.; Kaufmann, S. H. E.; Whitty, C. J. M.; Atun, R.; Zumla, A.: Tuberculosis 8 Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. The Lancet special issue: Tuberculosis, pp. 2179 - 2191 (2010)

Kaufmann, S. H. E.; Hussey, G.; Lambert, P.-H.: New vaccines for tuberculosis. The Lancet special issue: Tuberculosis, pp. 2110 - 2119 (2010)

Day, T. A.; Koch, M.; Nouailles, G.; Jacobsen, M.; Kosmiadi, G. A.; Miekley, D.; Kuhlmann, S.; Jörg, S.; Gamradt, P.; Mollenkopf, H. J. et al.; Hurwitz, R.; Reece, S. T.; Kaufmann, S. H. E.; Kursar, M.: Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis. European Journal of Immunology 40 (6), pp. 1663 - 1673 (2010)

Day, T. A.; Koch, M.; Nouailles, G.; Jacobsen, M.; Kosmiadi, G. A.; Miekley, D.; Kuhlmann, S.; Jörg, S.; Gamradt, P.; Mollenkopf, H. J. et al.; Hurwitz, R.; Reece, S. T.; Kaufmann, S. H. E.; Kursar, M.: Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis. European Journal of Immunology 40 (6), pp. 1663 - 1673 (2010)

Emoto, M.; Yoshida, T.; Fukuda, T.; Kawamura, I.; Mitsuyama, M.; Kita, E.; Hurwitz, R.; Kaufmann, S. H. E.; Emoto, Y.: alpha-Galactosylceramide Promotes Killing of Listeria monocytogenes within the Macrophage Phagosome through Invariant NKT-Cell Activation. Infection and Immunity 78 (6), pp. 2667 - 2676 (2010)

Emoto, M.; Yoshida, T.; Fukuda, T.; Kawamura, I.; Mitsuyama, M.; Kita, E.; Hurwitz, R.; Kaufmann, S. H. E.; Emoto, Y.: alpha-Galactosylceramide Promotes Killing of Listeria monocytogenes within the Macrophage Phagosome through Invariant NKT-Cell Activation. Infection and Immunity 78 (6), pp. 2667 - 2676 (2010)

Parida, S. K.; Kaufmann, S. H. E.: Novel tuberculosis vaccines on the horizon. Current Opinion in Immunology 22 (3), pp. 374 - 384 (2010)

Ehlers, S.; Kaufmann, S. H. E.: Infection, inflammation, and chronic diseases: consequences of a modern lifestyle. Trends in Immunology 31 (5), pp. 184 - 190 (2010)

Emoto, M.; Emoto, Y.; Yoshizawa, I.; Kita, E.; Shimizu, T.; Hurwitz, R.; Brinkmann, V.; Kaufmann, S. H. E.: alpha-GalCer ameliorates listeriosis by accelerating infiltration of Gr-1(+) cells into the liver. European Journal of Immunology 40 (5), pp. 1328 - 1341 (2010)

Emoto, M.; Emoto, Y.; Yoshizawa, I.; Kita, E.; Shimizu, T.; Hurwitz, R.; Brinkmann, V.; Kaufmann, S. H. E.: alpha-GalCer ameliorates listeriosis by accelerating infiltration of Gr-1(+) cells into the liver. European Journal of Immunology 40 (5), pp. 1328 - 1341 (2010)

Fears, R.; Kaufmann, S. H. E.; ter Meulen, V.; Zumla, A.: Drug-resistant tuberculosis in the European Union: Opportunities and challenges for control. Tuberculosis 90 (3), pp. 182 - 187 (2010)